MarketPeel
Insider Trading Intelligence
BL

Brian Guan-chyun Liu

CGON
DIRECTOR · CG ONCOLOGY, INC. · CIK 0002007835
FILING MIX · LIFETIME100%/0%
BUYS
5
SELLS
0
TOTAL VALUE
$74.81M
COMPANIES
1
ACTIVE SINCE
Oct 2024
HOLDINGS NOW
1,886,236
AVG SELL PX
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Brian Guan-chyun Liu, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+17.07%+0.70%+16.36%+16.36%
14d1+100.00%+10.01%+0.06%+9.95%+9.95%
30d1+100.00%+30.43%-0.70%+31.13%+31.13%
60d1+100.00%+21.29%+3.62%+17.67%+17.67%
90d1+100.00%+25.88%+4.55%+21.32%+21.32%
180d1+100.00%+89.36%+2.97%+86.38%+86.38%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CGON · 1,886,236 shares · as of Jun 25, 2026
0471,559943,1181,414,6771,886,23620252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
2026
2026
FLOW · 5 buys / 0 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CGON
CG ONCOLOGY, INC.
PURCHASE10b5-1
10b5-1 plan
371,085$66.87$24.81M1,886,236Jun 25, 2026Jun 29, 2026View →
CGON
CG ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
9,3549,354Jun 4, 2026Jun 5, 2026View →
CGON
CG ONCOLOGY, INC.
PURCHASE10b5-1
10b5-1 plan
1,515,151$33.00$50.00M1,515,151Sep 11, 2025Sep 12, 2025View →
CGON
CG ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
24,16524,165Jun 5, 2025Jun 5, 2025View →
CGON
CG ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
15,60015,600Oct 4, 2024Oct 7, 2024View →
Other insiders · CGON
Loading peer insiders…
About this filer
CIK 0002007835
ROLE
Director
PRIMARY
CGON
COMPANIES
1
ACTIVE SINCE
Oct 2024
MARKETPEEL · /INSIDER/0002007835DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback